Design and arrangement of the CHIP (CHinese In Prato) survey;Disegno e modalità di realizzazione dello studio CHIP (CHinese In Prato)

Epidemiologia e Prevenzione

Volumn 38, Issue 6, 2014, Pages 357-363

  Modesti, Pietro Amedeo ^a,b   Han, Yang ^c   Jing, Yang ^a   Xiaoling, Wang ^a   Mengyue, Zhang ^a   Zihua, Yang ^a   Jia, Guo ^a   Perruolo, Eleonora ^a   Bini, Lara ^a   Camera, Maira ^a   Biggeri, Annibale ^a,d   Rapi, Stefano ^b   Hongsheng, Chen ^e   Li, Zhang ^e   Zengli, Wang ^f   Jianbin, Hu ^g   Xiaoyue, Zhao ^h   Zhao, Dong ⁱ  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda Ospedaliero Universitaria Careggi   (Italy)

^c Consolato generale della Repubblica popolare cinese a Firenze ^*  (Italy)

^d Struttura complessa di epidemiologia molecolare e nutrizionale   (Italy)

^e Associazione d amicizia dei cinesi a Prato   (Italy)

^f Sezione Prato   (Italy)

^g Associazione culturale cinese di Fujian a Prato   (Italy)

^h Associazione buddista della Comunità cinese   (Italy)

ⁱ Bejing Institute of Technology   (China)

Author keywords

Cardiovascular diseases; Diabetes; Elusive populations; Participant led research; Prevalence

Indexed keywords

CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS; ETHNOLOGY; HUMAN; INCIDENCE; ITALY; MIGRATION; PREVALENCE; RISK FACTOR; SPAIN; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; CHINA; DIABETES MELLITUS; HUMANS; INCIDENCE; ITALY; PREVALENCE; RISK FACTORS; SPAIN; TRANSIENTS AND MIGRANTS;

EID: 84946213503     PISSN: 11209763     EISSN: 23851937     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wang MA, Moran AE, Liu J et al. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes 2014;7(1): 78-85.
2. Zhao D, Liu J, Wang W et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008;39(6):1668-74.
3. Wang X, Bots ML, Yang F, Hoes AW, Vaartjes I. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens 2014;32(10):1919-27.
4. Xu G, Ma M, Liu X, Hankey GJ. Is there a stroke belt in China and why? Stroke 2013;44(7):1775-83.
5. Xu Y, Wang LM, He J et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;31089):948-59.
6. Bi Y, Xu Y, Li M et al. Prevalence and Control of Diabetes in Chinese Adults: The China Metabolic Risk Factor Study. Circulation 2013;127:A011.
7. Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet 2013; 381(9873):1235-45.
8. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104(22):2746-53.
9. Modesti PA, Bianchi S, Borghi C et al. Cardiovascular health in migrants: current status and issues for prevention. A collaborative mul-tidisciplinary task force report. J Cardiovasc Med (Hagerstown) 2014; 15(9):683-92.
10. 10.Modesti PA, Agostoni P, Agyemang C et al. Cardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource Settings. J Hypertens 2014; 32(5):951-60.
11. 11.Modesti PA, Rapi S, Bamoshmoosh M et al. Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. BMJ Open 2012;2(4).
12. 12.Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Blood pressure 2013;22(4):193-278.
13. 13.Modesti PA, Bamoshmoosh M, Rapi S et al. Relationship between hypertension, diabetes and proteinuria in rural and urban households in Yemen. J Hum Hypertens 2013;27(9):572-9.
14. 14.Modesti PA, Massetti L, Bamoshmoosh M, Baldereschi M, Cambi GE, Rapi S. The impact of fine-tuning of optical recognition system on database reliability. Comput Biol Med 2012;42(7):778-83.
15. 15.Modesti PA, Bamoshmoosh M, Rapi S, Massetti L, Al-Hidabi D, Al Goshae H. Epidemiology of hypertension in Yemen: effects of urbanization and geographical area. Hypertens Res 2013;36(8):711-7.
16. 16.The L. Preventing hypertension: a hopeless dream? Lancet 2012; 380(9841):538.
17. 17.Rapsomaniki E, Timmis A, George J et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014;383(9932):1899-911.
18. 18.Lackland DT, Roccella EJ, Deutsch AF et al. Factors influencing the decline in stroke mortality: a statement from the American Heart As-sociation/American Stroke Association. Stroke 2014;45(1):315-53.
19. 19.Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009. Eur Heart J 2013;34(39):3017-27.
20. 20.Anderson GM, Bronskill SE, Mustard CA, Culyer A, Alter DA, Manuel DG. Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities. J Clin Epidemiol 2005;58(8):757-62.
21. 21.Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997;78(6):555-63.
22. 22.Cappuccio FP, Micah FB, Emmett L et al. Prevalence, detection, management, and control of hypertension in Ashanti, West Africa. Hypertension 2004;43(5):1017-22.
23. 23.Lambie M, Richards N, Smith S. Ethnicity, age and incidence rates for renal replacement therapy (RRT) in Birmingham, UK: 1990-2004. Nephrol Dial Transplant 2008;23(12):3983-7.
24. 24.Roderick PJ, Jones I, Raleigh VS, McGeown M, Mallick N. Population need for renal replacement therapy in Thames regions: ethnic dimension. BMJ 1994;309(6962):1111-4.
25. 25.Lightstone L, Rees AJ, Tomson C, Walls J, Winearls CG, Feehally J. High incidence of end-stage renal disease in Indo-Asians in the UK. QJM 1995;88(3):191-5.
26. 26.Harland JO, Unwin N, Bhopal RS et al. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. J Epidemiol Comm Health 1997;51(6):636-42.